Following the recommendation of the European Medicines Agency’s Committee for Advanced Therapies (CAT), the organisation last week advised patients against using unproved and unregulated cell therapies, citing serious and potentially fatal side effects.

“The CAT’s advice is in response to individuals, companies and hospitals promoting unproven cell-based therapies as cures for a broad range of conditions including cancer, cardiovascular diseases, autism, cerebral palsy, muscular dystrophy and vision loss. These treatments can pose serious risks to patients for little or no benefit.”

The full statement is available here.